“Nuestra apuesta por la calidad y experiencia nos permiten una ventaja de 6 a 8 meses en el acceso a ensayos clínicos innovadores” Published on 25/10/2024 Recibimos la visita del Dr. Jordi Rodón, responsable de la Unidad de Desarrollo de fármacos en etapa temprana de MD Anderson Houston. Rodón está especializado en el desarrollo temprano de fármacos, el descubrimiento de biomarcadores, la medicina personalizada del cáncer y la Neurooncología.
The potential of a protein called L1CAM as one of the most promising treatment targets in cancer Published on 17/01/2020 The results have recently been published of a study that promise to change the way we deal with cancer.
How to survive a presidential session of ESMO (and speak to over 6,000 people) Published on 08/10/2019 I was just about to leave for my summer holiday. In fact, I was at the airport with my wife and daughter when the phone rang. I already knew the call would come, and I was awaiting it with anxiety/fear and excitement in equal measures.